CVS Group (CVSG) Price Target Raised to GBX 1,350

CVS Group (LON:CVSG) had its price objective raised by Peel Hunt from GBX 1,050 ($13.72) to GBX 1,350 ($17.64) in a research report sent to investors on Thursday morning. Peel Hunt currently has a buy rating on the stock.

Several other equities research analysts have also recently issued reports on CVSG. Berenberg Bank cut their price target on CVS Group from GBX 1,450 ($18.95) to GBX 1,250 ($16.33) and set a buy rating for the company in a research note on Monday, October 1st. Royal Bank of Canada lowered their price objective on shares of CVS Group from GBX 1,190 ($15.55) to GBX 1,180 ($15.42) and set an outperform rating for the company in a research report on Tuesday, October 23rd.

Shares of LON:CVSG opened at GBX 618.06 ($8.08) on Thursday. CVS Group has a one year low of GBX 13.22 ($0.17) and a one year high of GBX 1,500 ($19.60).

The company also recently disclosed a dividend, which was paid on Friday, December 7th. Shareholders of record on Thursday, November 22nd were given a dividend of GBX 5 ($0.07) per share. This is an increase from CVS Group’s previous dividend of $4.50. This represents a yield of 0.52%. The ex-dividend date was Thursday, November 22nd.

In other news, insider Richard Fairman acquired 1,450 shares of the stock in a transaction on Monday, December 3rd. The stock was acquired at an average cost of GBX 651 ($8.51) per share, for a total transaction of £9,439.50 ($12,334.38).

About CVS Group

CVS Group plc provides veterinary services in the United Kingdom. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste collection services for veterinary practices and directly for pet owners.

See Also: Balanced Fund

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with's FREE daily email newsletter.

Leave a Reply